Serious adverse events of reduced visual acuity and eye inflammation were observed in 2 clinical trials.
Connor Iapoce
Advertisement
Articles by Connor Iapoce
The low-dose cohort of RP-A501 conferred cardiac LAMP2B transgene expression.
A new study presented at ASGCT found that patients with indications of hemostatic efficacy experienced few adverse effects with gene therapy treatment BAY 2599023.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
3
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
4
